Skip to content

Drug interactions

Lisocabtagene maraleucel + Methylprednisolone

Severity: Major

Lisocabtagene maraleucel and Methylprednisolone: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Corticosteroids are lymphotoxic and can impair the expansion and persistence of CAR-T cells, potentially reducing efficacy. They also add to infection risk in patients who are already immunocompromised. However, corticosteroids are standard treatment for cytokine release syndrome and neurotoxicity after infusion.

What this interaction means in plain words

Lisocabtagene maraleucel and Methylprednisolone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Lisocabtagene maraleucel belongs to Oncology; Methylprednisolone belongs to Endocrine.

Evidence level: Moderate

Why it happens

Pharmacodynamic antagonism: glucocorticoid-mediated suppression and lysis of T lymphocytes may blunt CAR-T cell activity and add to immunosuppression.

What to do

Avoid prophylactic or premedication use of systemic methylprednisolone around CAR-T infusion. Reserve it for treating cytokine release syndrome or neurologic toxicity according to protocol, and monitor for infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lisocabtagene maraleucel and Methylprednisolone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lisocabtagene maraleucel with Methylprednisolone?

MediHelp rates the interaction as major. Lisocabtagene maraleucel and Methylprednisolone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Corticosteroids are lymphotoxic and can impair the expansion and persistence of CAR-T cells, potentially reducing efficacy. They also add to infection risk in patients who are already immunocompromised. However, corticosteroids are standard treatment for cytokine release syndrome and neurotoxicity after infusion.

How serious is the interaction between Lisocabtagene maraleucel and Methylprednisolone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid prophylactic or premedication use of systemic methylprednisolone around CAR-T infusion. Reserve it for treating cytokine release syndrome or neurologic toxicity according to protocol, and monitor for infection.

What other medicines interact with Methylprednisolone?

MediHelp also lists interactions of Methylprednisolone with, for example, Bcg vaccine live, Measles mumps and rubella vaccine live, Measles mumps rubella and varicella vaccine live. The full list is on the Methylprednisolone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in